Charles River Laboratories International, Inc. (CRL)
NYSE·Healthcare·Medical - Diagnostics & Research
$182.66
-1.08%
Mkt Cap $9.14B
Analyst Ratings
Buy
9
Hold
3
Sell
0
Price Target (33 analysts)
$202.17
Range $175.00 – $260.00
Implied Upside
+10.7%
Consensus $202.17 vs current $182.66